{"id":198432,"date":"2026-05-21T15:22:54","date_gmt":"2026-05-21T13:22:54","guid":{"rendered":"https:\/\/www.bordeaux-neurocampus.fr\/la-satt-aquitaine-investit-dans-une-approche-theranostique-portee-par-clement-morgat\/"},"modified":"2026-05-21T15:46:52","modified_gmt":"2026-05-21T13:46:52","slug":"la-satt-aquitaine-investit-dans-une-approche-theranostique-portee-par-clement-morgat","status":"publish","type":"post","link":"https:\/\/www.bordeaux-neurocampus.fr\/en\/la-satt-aquitaine-investit-dans-une-approche-theranostique-portee-par-clement-morgat\/","title":{"rendered":"La SATT Aquitaine investit dans une approche th\u00e9ranostique port\u00e9e par Cl\u00e9ment Morgat"},"content":{"rendered":"<p><span id=\"hs_cos_wrapper_post_body\" class=\"hs_cos_wrapper hs_cos_wrapper_meta_field hs_cos_wrapper_type_rich_text\" data-hs-cos-general-type=\"meta_field\" data-hs-cos-type=\"rich_text\"> <img loading=\"lazy\" decoding=\"async\" class=\"alignright wp-image-139527\" src=\"https:\/\/cdn-neurocampus.onlc.eu\/wp-content\/uploads\/2018\/07\/morgat-DSC_7378-270x360.jpg\" alt=\"\" width=\"188\" height=\"251\" srcset=\"https:\/\/www.bordeaux-neurocampus.fr\/wp-content\/uploads\/2018\/07\/morgat-DSC_7378-270x360.jpg 270w, https:\/\/www.bordeaux-neurocampus.fr\/wp-content\/uploads\/2018\/07\/morgat-DSC_7378-578x770.jpg 578w, https:\/\/www.bordeaux-neurocampus.fr\/wp-content\/uploads\/2018\/07\/morgat-DSC_7378.jpg 600w\" sizes=\"auto, (max-width: 188px) 100vw, 188px\" \/>La SATT Aquitaine soutient le d\u00e9veloppement d\u2019une innovation m\u00e9dicale prometteuse issue de la recherche bordelaise. Ce projet a pour ambition d\u2019am\u00e9liorer \u00e0 la fois le diagnostic et le traitement de cancers particuli\u00e8rement agressifs, comme le cancer du pancr\u00e9as, \u00e0 l\u2019aide d\u2019une approche innovante appel\u00e9e th\u00e9ranostique. Port\u00e9 par le Pr Cl\u00e9ment Morgat, chercheur \u00e0 l&#8217;INCIA, PU-PH \u00e0 l\u2019Universit\u00e9 de Bordeaux et praticien au CHU de Bordeaux, <strong>ce projet vise \u00e0 d\u00e9velopper un m\u00e9dicament radiopharmaceutique (MRP) ciblant un r\u00e9cepteur de type neuropeptide<\/strong>, une cible prometteuse dans des cancers de tr\u00e8s mauvais pronostic.<\/span><\/p>\n<p><span id=\"hs_cos_wrapper_post_body\" class=\"hs_cos_wrapper hs_cos_wrapper_meta_field hs_cos_wrapper_type_rich_text\" data-hs-cos-general-type=\"meta_field\" data-hs-cos-type=\"rich_text\">Pour accompagner cette innovation jusqu\u2019aux premi\u00e8res \u00e9tapes cliniques, la SATT Aquitaine engage un investissement global de 615 000 \u20ac, incluant 80 000 \u20ac d\u00e9di\u00e9s \u00e0 la propri\u00e9t\u00e9 intellectuelle, dans un programme de maturation. Il permettra une premi\u00e8re \u00e9tude clinique d\u2019imagerie de phase I afin d\u2019\u00e9valuer la s\u00e9curit\u00e9, le comportement biologique, et la sp\u00e9cificit\u00e9 de la captation, d\u2019identifier les patients \u00e9ligibles et de s\u00e9lectionner trois compos\u00e9s th\u00e9rapeutiques \u00e0 \u00e9valuer pr\u00e9-cliniquement in vitro et in vivo.<\/span><\/p>\n<p><a href=\"https:\/\/blog.ast-innovations.com\/satt-aquitaine-investissement-approche-th%C3%A9ranostique-pour-mieux-diagnostiquer-traiter-cancers-agressifs\"><strong>En savoir plus : lire de communiqu\u00e9 de la SATT<\/strong><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>D\u00e9veloppement d&#8217;un m\u00e9dicament radiopharmaceutique ciblant un r\u00e9cepteur de type neuropeptide<\/p>\n","protected":false},"author":108,"featured_media":171303,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[443],"tags":[],"class_list":["post-198432","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-innovation-en"],"_links":{"self":[{"href":"https:\/\/www.bordeaux-neurocampus.fr\/en\/wp-json\/wp\/v2\/posts\/198432","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.bordeaux-neurocampus.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.bordeaux-neurocampus.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.bordeaux-neurocampus.fr\/en\/wp-json\/wp\/v2\/users\/108"}],"replies":[{"embeddable":true,"href":"https:\/\/www.bordeaux-neurocampus.fr\/en\/wp-json\/wp\/v2\/comments?post=198432"}],"version-history":[{"count":2,"href":"https:\/\/www.bordeaux-neurocampus.fr\/en\/wp-json\/wp\/v2\/posts\/198432\/revisions"}],"predecessor-version":[{"id":198442,"href":"https:\/\/www.bordeaux-neurocampus.fr\/en\/wp-json\/wp\/v2\/posts\/198432\/revisions\/198442"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.bordeaux-neurocampus.fr\/en\/wp-json\/wp\/v2\/media\/171303"}],"wp:attachment":[{"href":"https:\/\/www.bordeaux-neurocampus.fr\/en\/wp-json\/wp\/v2\/media?parent=198432"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.bordeaux-neurocampus.fr\/en\/wp-json\/wp\/v2\/categories?post=198432"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.bordeaux-neurocampus.fr\/en\/wp-json\/wp\/v2\/tags?post=198432"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}